← Browse by Condition
Medical Condition
neoplasms
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 1, Phase 2, Phase 4, Phase 1
ClinicalMetric tracks all active clinical trials for neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — neoplasms Clinical Trials
How many clinical trials are currently recruiting for neoplasms?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neoplasms?
neoplasms research spans Phase 1 (5 trials), Phase 2 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neoplasms clinical trial?
Eligibility criteria for neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 5
Phase 2 3
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07354971
Recruiting
Enrollment
67 pts
Location
United Kingdom
Sponsor
University Hospital Southampto...
NCT07498725 Phase 1, Phase 2
Recruiting
Enrollment
120 pts
Location
France, United Kingd...
Sponsor
LARKSPUR BIOSCIENCES, INC.
NCT05440240 Phase 4
Recruiting
Enrollment
400 pts
Location
Denmark
Sponsor
Regionshospitalet Silkeborg
NCT04192344 Phase 1
Recruiting
Enrollment
276 pts
Location
United States, China
Sponsor
Abbisko Therapeutics Co, Ltd
NCT05176665 Phase 1, Phase 2
Recruiting
Enrollment
152 pts
Location
United States, China
Sponsor
Shanghai EpimAb Biotherapeutic...
NCT05940259
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Peking University First Hospit...
NCT06819215 Phase 1, Phase 2
Recruiting
Enrollment
188 pts
Location
China
Sponsor
Zhejiang Yangli Pharmaceutical...
NCT05013944
Recruiting
Enrollment
100,000 pts
Location
United States
Sponsor
Anova Enterprises, Inc
NCT04996732
Recruiting
Enrollment
500,000 pts
Location
China
Sponsor
Fudan University
NCT06884618 Phase 1
Recruiting
Enrollment
405 pts
Location
United States, Austr...
Sponsor
Hoffmann-La Roche
NCT04495790
Recruiting
Enrollment
500 pts
Location
United States
Sponsor
Advanced Integrative Medical S...
NCT05919758
Recruiting
Enrollment
1,000 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology